Evidence map›Paper›PMID 8326018›Full record

ArticleThe Journal of clinical investigation1993

Functional interleukin-2 receptors on intestinal epithelial cells.

C Ciacci, Y R Mahida, A Dignass, M Koizumi, D K Podolsky

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Cytokine responses and epithelial function in the intestinal mucosa.Cellular and molecular life sciences : CMLS · 2016
    Review
  8. Review
  9. Molecular mechanism of interleukin-2-induced mucosal homeostasis.American journal of physiology. Cell physiology · 2012
    Article
  10. Article
  11. Enteral versus parenteral nutrition: effect on intestinal barrier function.Annals of the New York Academy of Sciences · 2009
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

C CiacciDepartment of Medicine, Massachusetts General Hospital, Boston 02114.
Y R Mahida
A Dignass
M Koizumi
D K Podolsky
Massachusetts General Hospital · USHarvard University Press · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
PEPTIDE GROWTH FACTORS IN INTESTINAL EPITHELIAL REPAIRR37DK041557 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PODOLSKY, DANIEL K · 1997 to 2006
$2.9M
PEPTIDE GROWTH FACTORS IN INTESTINAL EPITHELIAL REPAIRR01DK041557 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PODOLSKY, DANIEL K · 1988 to 1997
–
NIDDK NIH HHS DK 41557NIDDK NIH HHS P30 DK43351
6 · The paper itself

Abstract

The presence of receptors for the cytokine IL-2 was assessed in the IEC-6 cell line established from normal rat crypt epithelium and primary intestinal epithelial cells. 125I-IL-2 was found to specifically bind to subconfluent IEC-6 cells. Maximal binding was observed within 30 min after addition of the ligand; binding could be inhibited by excess unlabeled IL-2 or addition of antibody to the IL-2 receptor. Both intermediate and low affinity receptors with approximate Kd of 10 and 100 pM, respectively were present. Kinetic analysis were consistent with the results of Western blot analysis using an antisera to the 75-kD IL-2 receptor beta chain. IL-2 receptors appeared to be functional; addition of IL-2 led to modulation of proliferation with initial stimulation at 24 h followed by inhibition at 48 h. This effect could be blocked by addition of antibody to the IL-2 receptor beta chain. IL-2 treatment could be shown to enhance expression (range = 4- to 50-fold stimulation) of TGF-beta, as well as the lectin protein mac-2, in IEC-6 cells. The relevance of observations in the IEC-6 cell line to intestinal mucosa in vivo was supported by the demonstration of a gradient of expression of the IL-2 receptor in primary rat intestinal epithelial cells by Western blot analysis. In addition, mRNA for the IL-2 receptor-beta chain was demonstrated by Northern blot analysis using mRNA from primary rat intestinal epithelial cells depleted of detectable contaminating intraepithelial lymphocytes by two cycles of fractionation on Percoll gradients. Collectively, these observations suggest that the range of cellular targets of the putative lymphokine IL-2 is broader than appreciated, and IL-2 may serve to integrate epithelial and lymphocyte responses in the intestinal mucosa.

Indexed as

AnimalsBase SequenceCell DivisionCells, CulturedEpithelial CellsEpitheliumGene ExpressionInterleukin-2Intestinal MucosaIn Vitro TechniquesMolecular Sequence DataOligodeoxyribonucleotidesRatsReceptors, Interleukin-2RNA, MessengerTransforming Growth Factor betaInterleukin-2OligodeoxyribonucleotidesReceptors, Interleukin-2RNA, MessengerTransforming Growth Factor beta

Identifiers

PMID8326018
PMCPMC293642
OpenAlexW2098778559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.